These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 562373)

  • 1. Negative seroconversion and circulating interferon in children vaccinated with live measles vaccine.
    Izbický A; Drevo M; Domorázková E; Slonin D
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):191-4. PubMed ID: 562373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1976; 30(2):235-41. PubMed ID: 945592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic response and post-vaccination reactions in children vaccinated against measles. II. Antibody levels and seroconversion following vaccination].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1974; 28(3):325-31. PubMed ID: 4471838
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
    Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reaction to vaccination and measles antibody levels in children inoculated with vaccine prepared from the L-16 strain from Japanese quail embryonic fibroblast cultures].
    Zespolowa P
    Przegl Epidemiol; 1975; 29(3):291-300. PubMed ID: 1178922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G; Petersen I; Mordhorst CH
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
    Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.